Feed NEU.AX
NE
Neuren Pharmaceuticals Limited
NEU.AX · ASX
$23.25 -1.65% (-$0.39)
1M +43.27%
Market Cap $3.0B
P/E Ratio 98.47x
Div. Yield -
ROE -
Bulios Fair Price
$30.46
31.0% upside
Preț actual
$23.25
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile NEU.AX sunt în prezent subevaluate față de prețul lor de piață. Cum funcționează?
Valuation
16 /100
Expensive EV/EBITDA 135.74x
P/S 46.37x
P/B 8.85x
Growth
100 /100
Growing Rev. growth 64.38%
FCF growth 227.18%
Book val. growth 101.14%
Profitability
100 /100
Strong Net margin 47.09%
Op. margin 34.07%
FCF margin 193.99%
Quality
35 /100
Average ROA 8.88%
Asset turnover 0.19x
ROIC 5.09%
Debt
100 /100
Low Current ratio 76.60x
Net debt/EBITDA -0.19x
Debt/Equity 0.00x
Stability
16 /100
Unstable Rev. volatility 885.34%
EPS volatility 49,454.87%
Profitable years 4
Întreabă StockBot despre NEU.AX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jonathan Charles Pilcher
Employees
9
Headquarters
Hawthorn East
Evenimente viitoare
25 AUG.
Earnings
Upcoming earnings report